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pen access Abstract In our screening program of the Egyptian wild and cultivated plants for antioxidant
compounds, four phenylethanoids were reported for the ﬁrst time from the wild Egyptian species
Blepharis edulis (Forssk.) Pers. family Acanthaceae. The antioxidant activity-guided chemical inves-
tigation of the methanolic fraction of the aerial part revealed the presence of verbascoside (1),
cis-verbascoside (2), isoverbascoside (3), Leucosceptoside A (4). The HPLC/UV characterization
of these compounds is found. The compounds were isolated and puriﬁed using silica gel column
chromatography and semi-preparative HPLC, the structures were identiﬁed and conﬁrmed by
UV, ESI-MS, MALDI-MS in addition to one and two dimensional NMR experiments. Antioxidant
activities of the main fractions of B. edulis extract were determined using the DPPH radical test.
ª 2012 Faculty of Pharmacy, Cairo University. Production and hosting by Elsevier B.V.
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Antioxidants are one of the most important nutraceutical com-
pounds that have emerged from the recent decades of researchahoo.com
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03.003
lsevier
under CC BY-NC-ND license.in food and pharmaceutical sciences. The advances in this ﬁeld
have allowed a better understanding of the free radical damage
of cellular constituents, such as lipids, proteins and DNA.
Antioxidants and radical scavengers have a crucial role in
the treatment or prevention of several diseases such as cancer,
atherosclerosis, diabetes, cardiovascular disorders and neuro-
degenerative disorders.1
Genus Blepharis (Acanthaceae) is composed of approxi-
mately 100 species with tropical and subtropical distribu-
tions. The genus is represented in Egypt only by Blepharis
edulis.2 Different Blepharis species demonstrated different
biological activities and are employed against numerous
diseases and as a health tonic.3,4 Although some of its mem-
bers are used ethnomedicinally, genus Blepharis has not been
investigated much.3 However some phytoconstituents are
reported to genus Blepharis including ﬂavonoids and
phenylethanoids.3,4
68 M.A.-G. AshourThe anti DPPH activity of the main fractions of the total
extract of B. edulis growing in Egypt has encouraged us to
continue separation and characterization of different constitu-
ents of each fraction. The present paper describes the isolation
and HPLC/UV characterization and structure elucidation of
four phenylethanoid derivatives from B. edulis.
2. Experimental
2.1. Material and methods
2.1.1. Plant material
The arial parts of the plant were collected from Sinai district
near Mount Catherine also known as Gebel Katherina, located
in Saint Katherine city, in the Southern provinces of Sinai Pen-
insula in Egypt and identiﬁed as B. edulis (Acanthaceae) by
Prof. Dr. Batanouny, K.H., Department of Botany, Faculty
of Science; Cairo University, Egypt. Corresponding specimens
deposited at the herbarium of the pharmacognosy department,
Faculty of Pharmacy, Al-Azhar University.
2.1.2. General procedures
1DNMR spectra including 1HNMR, 13C NMR, distortionless
enhancement by polarization transfer (DEPT) and 2D NMR
spectra including correlation spectroscopy, heteronuclear mul-
tiple quantum coherence and heteronuclear multiple bond con-
nectivity (COSY, HMQC and HMBC) were recorded, using
deuterated dimethylsulfoxide (DMSO-d6) as NMR solvent,
and tetramethylsilane (TMS) as the internal standard, on a
Bruker ARX 400 NMR spectrometer. ESI-MS spectra were
recorded on Finningan MAT TSQ-7000 mass spectrometer
coupled with HPLC. UV spectra were measured in methanol
on a Perkin-Elmer UV/Vis lambda spectrophotometer. Sol-
vents were distilled prior to use, and spectral grade solvents
were used for spectroscopic measurements. TLC was per-
formed on TLC plates pre-coated with silica gel F254 (Merck,
Darmstadt, Germany). For HPLC analysis, samples were in-
jected into an HPLC system with a photodiode array detector
(Dionex, Munich, Germany). The separation column
(125 · 4 mm, i.d.) was preﬁlled with C18 (Knauer, Berlin,
Germany). The plotting of the peaks was guided by UV–VIS
photodiode array detector operating in four different wave
lengths 235, 254, 280 and 340 nm. The solvent gradients used
started with 10:90 [MeOH 100%: nanopure H2O (adjusted to
pH 2 with o-phosphoric acid)], the commencing methanol ratio
was equilibrated for 5 min at 10%, then increased gradiently up
to 100% after 35 min., then washing with 100% MeOH for an
additional 10 min. The ﬂow rate of the mobile phase was at
1 ml/min. Semipreparative HPLC was performed on HPLC
system (Merck, Darmstadt, Germany) coupled with UV detec-
tor L7400 (UV detection at 235 nm), the separation column
(250 · 8 mm) pre-packed with Eurosphere C18 (Knauer, Ber-
lin, Germany). The compounds were eluted with solvent system
of MeOH/H2O, at a ﬂow rate of 5 ml/min. MALDI-TOF-MS
spectra were obtained on a Perspective Biosystems Voyager-
DE PRO MALDI-TOF mass spectrometer and on a Bruker
Esquire 2000 LC-MS system equipped with an electrospray
source. Sample application for MALDI-TOF-MS was carried
out directly on sample plates with a mixture of 1 lL of matrix
(saturated 2,5-dihydroxybenzoic acid in 50% acetontrile,
0.3%TFA) and 1 lL of a 50% MeOH solution containing
about 0.2 lg of the sample.2.1.3. Antiradical activity of different B. edulis fractions
To quantify the DPPH quenching activity, the modiﬁed meth-
od of5 was used. The MeOH DPPH (Sigma) solution was
prepared at the concentration of 22 g L1. Tested extracts were
dissolved in MeOH at different concentrations. A volume of
test solution (0.2 mL) was mixed with DPPH solution
(1.8 mL) and the absorbance of the mixture at 517 nm was
measured each minute during the ﬁrst 5 min of the experiment
and then each 5 min for the next 25 min. Using the recorded
data, scavenging effect r was calculated [r= (1  sample
absorbance/control absorbance) · 100)] (mean of the repeated
three measurements were recorded). The IC50 of extracts and
the time course of activity increase were drawn and the differ-
ences between the tested extracts were compared.
2.1.4. Extraction and isolation procedure
The aerial part (500 g) was extracted with 70% cold methanol.
The total alcohol extract (47 g) was subjected to vacuum liquid
chromatography using silica gel for column, where petroleum
ether (7.5 g), diethylether (6.08 g), ethyl acetate (4.3 g), metha-
nol (10.9 g) and aqueous (14.3 g) fractions were obtained.
Methanol subfraction was rechromatographed using silica
gel for column and dichloromethane (DCM): methanol
(MeOH) as mobile phase in different ratios [100:0ﬁ 50:50]
where 26 fractions were obtained [fraction BeAﬁ BeZ respec-
tively]. Fraction BeV corresponding to the mobile system
(DCM:MeOH, 7:3) was further chromatographed using silica
gel for column and (DCM:MeOH) as mobile phase where 10
fractions were obtained [fraction BeV1ﬁ BeV10 respectively].
Fraction BeV7 corresponding to the mobile system
(DCM:MeOH, 7:3) was further chromatographed using silica
gel for column and (DCM:MeOH) as mobile phase where 10
fractions were obtained [fraction BeV7-1ﬁ BeV7-10 respec-
tively]. All the above mentioned fractions and sub-fractions
were monitored by analytical HPLC. Fractions BeV7-5 and
BeV7-6 showed three closely related peaks in HPLC chromato-
gram with narrow retention time differences (16.74, 17.91 and
18.68 min) using reversed phase (RP) HPLC column. These
fractions were subjected to semipreparative HPLC separation
using RP column and MeOH: H2O as mobile gradient system,
the same as in the case of analytical HPLC without the addi-
tion of H3PO4, where compounds 1 (17.2 mg), 2 (6.42 mg) &
3 (9.3 mg) were obtained. Fraction BeV7-2 was re-puriﬁed
using semipreparative HPLC where compound 4 (11.62 mg)
is obtained. UV spectra of these compounds (1ﬁ 4) are
presented in Fig. 1.
3. Results
The separate fractions were tested for anti-radical activity. The
DPPH quenching assay identiﬁed the promising activity of the
EtOEt, EtOAc and MeOH fractions as shown in Table 1.
Compound 1: It was isolated as a yellowish amorphous solid
(17.2 mg). HPLC. Rt 16.74 min. UV spectrum showed absorp-
tion maxima at kmax MeOH: 200, 219, 287 sh., and 331 nm
(Fig. 2). MALDI-TOF-MS m/z: 647 [M+Na]+.
1H NMR (DMSO-d6): Aglycone 6.59 (1H, d, J= 1.9, H-
2), 6.61 (1H, d, J= 7.2, H-5), 6.48 (1H, dd, J= 1.9 and 7.2,
H-6), 3.58 (1H, m, Ha-a), 3.87 (1H, m, Ha-b), 2.68 (2H, m,
H-b). Glucose 4.34 (1H, d, J= 7.6, H-10), 3.31 (1H, m, H-
20), 3.7 (1H, t, J= 9.5, H-30), 4.71 (1H, t, J= 9.5, H-40),
3.49 (1H, m, H-50), 3.35 (1H, m, H-60a), 3.41 (1H, m, H-60b),
OH
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Figure 1 Structures of the isolated phenylethanoids (compounds
1–4).
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(1H, m, H-300), 3.15 (1H, t, J= 9.5, H-400), 3.38 (1H, m, H-
500), 0.94 (3H, d, J= 6.9, H-600). Caffeic acid: 7.01 (1H, d,
J= 1.6, H-200 0), 6.74 (1H, d, J= 8.2, H-500 0), 6.96 (1H, dd,
J= 1.6 and 8.2, H-600 0), 6.18 (1H, d, J= 15.8, H-a),7.46
(1H, d, J= 15.8, H-b).
13C NMR (DMSO-d6): Aglycon 129.0 (C-1), 116.3 (C-2),
145.0 (C-3), 143.5 (C-4), 115.7(C-5), 119.5 (C-6), 70.5 (a-
CH2), 35.0 (b-CH2). Glucose 102.2 (C-10), 74.0 (C-20), 79.0
(C-30), 69.1 (C-40), 74.4 (C-50), 60.7 (C-60). Rhamnose 101.2
(C-100), 70.5 (C-200), 70.3 (C-300), 71.6 (C-400), 68.7 (C-500), 18.1
(C-600). Caffeic acid 165.7 (C‚O), 113.5 (a-CH), 145.5 (b-
CH), 125.5 (C-100 0), 114.7 (C-200 0), 145.0 (C-300 0), 148.5 (C-400 0),
115.4 (C-500 0), 121.4 (C-600 0).
Compound 2: It was isolated as yellowish amorphous solid
(6.42 mg). HPLC. Rt 17.91 min. UV spectrum showed absorp-
tion maxima at kmax MeOH: 200, 218 sh., 288 sh., and 330 nm
(Fig. 2). MALDI-TOF-MS m/z: 647 [M+Na]+.
1H NMR (DMSO-d6): Aglycone: 6.59 (1H, d, J= 1.9, H-
2), 6.61 (1H, d, J= 7.2, H-5), 6.48 (1H, dd, J= 1.9 and 7.2,
H-6), 3.58 (1H, m, Ha-a), 3.87 (1H, m, Ha-b), 2.68 (2H, m,
H-b). Glucose 4.36 (1H, d, J= 7.6, H-10), 3.21 (1H, m, H-
20), 3.72 (1H, t, J= 9.5, H-30), 4.67 (1H, t, J= 9.5, H-40),
3.45 (1H, m, H-50), 3.32 (1H, m, H-60a), 3.41 (1H, m, H-60b),
Rhamnose 5.05 (1H, br.s, H-100), 3.69 (1H, br s, H-200), 3.28
(1H, m, H-300), 3.19 (1H, t, J= 9.5, H-400), 3.41 (1H, m, H-
500), 1.05 (3H, d, J= 6.0, H-600). Caffeic acid: 7.47 (1H, d,
J= 1.9, H-200 0), 6.99 (1H, d, J= 8.2, H-500 0), 7.14 (1H, dd,
J= 1.9 and 8.2, H-600 0), 5.68 (1H, d, J= 12.5, H-a), 6.84
(1H, d, J= 12.5, H-b).
13C NMR (DMSO-d6): Aglycon 129.0 (C-1), 116.3 (C-2),
145.0 (C-3), 143.5 (C-4), 115.7(C-5), 119.5 (C-6), 70.5 (a-
CH2), 35.0 (b-CH2). Glucose 102.2 (C-10), 74.0 (C-20), 79.0
(C-30), 69.1 (C-40), 74.4 (C-50), 60.7 (C-60). Rhamnose 101.2
(C-100), 70.5 (C-200), 70.3 (C-300), 71.6 (C-400), 68.7 (C-500), 18.0Table 1 Comparison between the antioxidant activities (50% inhibit
edulis, IC50).
Fraction Total extract Petroleum ethe
Antioxidant activity IC50 (lg/mL) 289 635(C-600). Caffeic acid 166.0 (C‚O), 114.1 (a-CH), 144.5
(b-CH), 125.3 (C-100 0), 118.0 (C-200 0), 145.2 (C-300 0), 147.5 (C-
400 0), 113.5 (C-500 0), 124.0 (C-600 0).
Compound 3: It was isolated as a yellowish amorphous solid
(9.3 mg). HPLC. Rt 18.68 min. UV spectrum showed absorp-
tion maxima closely similar to those of compounds 1 and 2
at kmax MeOH: 202, 218, 288 sh., and 328 nm (Fig. 2). MAL-
DI-TOF-MS m/z: 647 [M+Na]+.
1H NMR (DMSO-d6): Aglycone 6.59 (1H, d, J= 1.6, H-
2), 6.57 (1H, d, J= 7.9, H-5), 6.44 (1H, dd, J= 1.6 and 7.9,
H-6), 3.57 (1H, m, Ha-a), 3.78 (1H, m, Ha-b), 2.68 (2H, m,
H-b). Glucose 4.27 (1H, d, J= 7.6, H-10), 3.11 (1H, m, H-
20), 3.4 (1H, t, J= 9.2, H-30), 3.38 (1H, m, H-40), 3.47 (1H,
m, H-50), 4.18 (1H, dd, J= 6.0 and 12.0, H-60a), 4.35 (1H,
d, J= 12.0, H-60b), Rhamnose 5.01 (1H, br.s, H-100), 3.68
(1H, br.s, H-200), 3.45 (1H, m, H-300), 3.16 (1H, m, H-400),
3.38 (1H, dt, J= 12.0 and 6.0,H-500), 0.94 (3H, d, J= 6.2,
H-600). Caffeic acid: 7.05 (1H, d, J= 1.6, H-200 0), 6.75 (1H, d,
J= 8.2, H-500 0), 6.96 (1H, dd, J= 1.6 and 8.2, H-600 0), 6.28
(1H, d, J= 15.8, H-a), 7.46 (1H, d, J= 15.8, H-b).
13C NMR (DMSO-d6): Aglycon 129.1 (C-1), 116.3 (C-2),
145.0 (C-3), 143.5 (C-4), 115.4(C-5), 119.5 (C-6), 70.6 (a-
CH2), 35.1 (b-CH2). Glucose 102.6 (C-10), 74.1 (C-20), 80.8
(C-30), 68.5 (C-40), 70.3 (C-50), 64.5 (C-60). Rhamnose 100.6
(C-100), 70.6 (C-200), 73.5 (C-300), 72.0 (C-400), 68.1 (C-500), 17.8
(C-600). Caffeic acid 166.5 (C‚O), 113.8 (a-CH), 145.3 (b-
CH), 125.5 (C-100 0), 114.9 (C-200 0), 145.5 (C-300 0), 148.4 (C-400 0),
115.7 (C-500 0), 121.4 (C-600 0).
Compound 4: It was isolated as a yellowish amorphous solid
(11.62 mg). HPLC. Rt 20.59 min. UV spectrum also showed
absorption maxima closely similar to those of compounds 1,
2 and 3 at kmax MeOH: 205, 219, 288 sh., and 330 nm
(Fig. 2). MALDI-TOF-MS m/z: 661 [M+Na]+.
1H NMR (DMSO-d6): Aglycone: 6.61 (1H, d, J= 1.2, H-
2), 6.64 (1H, d, J= 7.9, H-5), 6.58 (1H, dd, J= 1.2 and 7.9,
H-6), 3.58 (1H, dd, J= 16.2 and 7.2, Ha-a), 3.88 (1H, dd,
J= 16.2 and 7.9, Ha-b), 2.69 (2H, m, H-b). Glucose 4.35
(1H, d, J= 7.9, H-10), 3.2 (1H, dd, J= 8.2 and 7.9, H-20),
3.69 (1H, t, J= 8.9, H-30), 4.70 (1H, t, J= 8.9, H-40), 3.46
(1H, m, H-50), 3.31 (1H, m, H-60a), 3.41 (1H, m, H-60b),
Rhamnose 5.01 (1H, br.s, H-100), 3.24 (1H, m, H-200), 3.70
(1H, m, H-300), 3.11 (1H, dd, J= 3.1 & 8.8, H-400), 3.35 (1H,
m, H-500), 0.96 (3H, d, J= 6.3, H-600). Ferulic acid: 7.28 (1H,
br s, H-200 0), 6.74 (1H, d, J= 7.9, H-500 0), 6.96 (1H, dd,
J= 1.2 and 7.9 H-600 0), 6.41 (1H, d, J= 15.8, H-a), 7.53
(1H, d, J= 15.8, H-b), 3.8 (3H, s, 300 0-OMe).
13C NMR (DMSO-d6): Aglycon 129.1 (C-1), 116.3 (C-2),
145.0 (C-3), 143.6 (C-4), 115.5(C-5), 119.6 (C-6), 70.3 (a-
CH2), 35.0 (b-CH2). Glucose 102.3 (C-10), 74.5 (C-20), 79.13
(C-30), 69.1 (C-40), 74.6 (C-50), 60.7 (C-60). Rhamnose 101.3
(C-100), 70.4 (C-200), 70.5 (C-300), 71.7 (C-400), 68.8 (C-500), 18.1
(C-600). Ferulic acid 165.8 (C‚O), 114.14 (a-CH), 145.5
(b-CH), 125.6 (C-100 0), 111.1 (C-200 0), 147.9 (C-300 0), 149.4 (C-
400 0), 115.5 (C-500 0), 123.2 (C-600 0), 55.7 (300 0-OMe).ory concentration in mgs dried fractions of the total extract of B.
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Figure 2 UV spectra of the isolated phenylethanoids (compounds 1–4).
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Compound 1: MALDI-TOF-MS spectrum showed a pseudo-
molecular ion peak at m/z 647 [M+Na]+ which is consistent
with the molecular formula C29H36O15Na., ESI-MS spectrum
showed a quasimolecular ion peak at m/z 642 [M+H2O]
+,
while ESI-MS/MS fragmentation spectrum showed fragment
ion peak at m/z 460 [M-caffeoyl moiety]+, 486 [M-aglycone
moiety]+. Chemical structures of 1 were determined by utiliz-
ing 1D 1H NMR and 13C NMR spectra as well as 2D COSY,
HMBC and HMQC spectra. Signiﬁcant features visible from
the NMR spectra for 1 were two anomeric proton signals in
the 1H NMR spectrum observed at dH 4.34 (1H, d,
J= 7.6 Hz, H-10), 5.01 (1H, br.s, H-100), indicating the pres-
ence of two sugar moieties, conﬁrmed as b-glucopyranose
and a-rhamnopyranose, respectively, from HMQC and
HMBC experiments. The site of connection of rhamnosyl moi-
ety to glucosyl one was conﬁrmed by the HMBC correlation
between H-100 of the rhamnose and C-30 of the glucose indicat-
ing an interglycosidic linkage of the C-100(rha)ﬁ C-30(glu).Compound 1 showed a correlation between H-10 of the gluco-
pyranose unit with C-a of the phenyl ethyl aglycone in the
respective HMBC conﬁrming the position of the aglycone in
the structures. While the 13C NMR spectra of 1 showed the
presence of a carbonyl carbon (dC = 165.7) characteristic of
ester carbonyls, the ester linkage was observed from H-4’ of
the glucopyranose unit to the carbonyl carbon (C-100 0) of the
caffeoyl unit of verbascoside (1). The geometric isomerism of
the caffeoyl moiety was established to be E-isomerism through
the coupling constants between H-a at dH 6.18 (1H, d,
J= 15.8, H-a), and H-b at dH 7.46 (1H, d, J= 15.8, H-b)
of the acyl moiety. The complete assignment of all proton
and carbon resonances was based on the COSY, HMQC,
and HMBC experiments and compared well with those from
the literatures.6–9 Thus compound 1 was found to be 3,4-dihy-
droxy-b-phenylethoxy-O-[40-E-caffeoyl-a-rhamnopyranosyl-
(100,30)-O-b-glucopyranoside], known as verbascoside.
Compound 2: Similar to compound 1, MALDI-TOF-MS
spectrum of compound 2 showed a pseudomolecular ion peak
at m/z 647 [M+Na]+ which is consistent with the molecular
Isolation, HPLC/UV characterization and antioxidant activity of phenylethanoids 71formula C29H36O15Na., ESI-MS spectrum showed quasimo-
lecular ion peak at m/z 642 [M+H2O]
+, while ESI-MS/MS
fragmentation spectrum showed fragment ion peaks at m/z
460 [M-caffeoyl moiety]+, 486 [M-aglycone moiety]+. The
complete assignment of all proton and carbon resonances
was based on the 1H, 13C, DEPT, COSY, HMQC, and HMBC
experiments, while the difference between compound 1 and 2
was only the geometric isomerism at the double bond between
C-a and C-b of the caffeoyl moiety where it was conﬁrmed to
be Z-isomerism in compound 2 instead of E-isomerism in the
case of 1. This conﬁrmation was achieved through the coupling
constants between H-a at dH 5.68 (1H, d, J= 12.5, H-a) and
H-b at dH 6.84 (1H, d, J= 12.5, H-b) of the acyl moiety.
Considering the above mentioned data and comparing with
those of the literatures,10,11 Compound 2 was found to be
3,4-dihydroxy-b-phenylethoxy-O-[40-Z-caffeoyl-a-rhamnopyr-
anosyl-(100,30)-O-b-glucopyranoside], known as cis-verbasco-
side (also known as cis-acteoside).
Compound 3: MALDI-TOF-MS spectrum of compound 3
is found to be similar to those of compounds 1and 2, showed
a pseudomolecular ion peak at m/z 647 [M+Na]+ which is
consistent with the molecular formula C29H36O15Na., ESI-
MS spectrum showed a quasimolecular ion peak at m/z 625
[M+H]+, while ESI-MS/MS showed fragment ion peaks at
m/z 460 [M-caffeoyl moiety]+, 486 [M-aglycone moiety]+.
The complete assignment of all proton and carbon resonances
was based on the 1H, 13C, DEPT, COSY, HMQC, and HMBC
experiments, while compound 3 is different from 1 only in the
position of the ester bond. This bond was found to be located
between C‚O of the caffeoyl moiety and C-60 of the glucose
moiety as conﬁrmed through HMBC experiment as well as
the downﬁeld-shift of C-60 of glucose moiety at 64.5 ppm.
From the above mentioned data and comparing with the
literatures.8,9 compound 3 was conﬁrmed as 3,4-dihydroxy-b-
phenylethoxy-O-[60-E-caffeoyl-a-rhamnopyranosyl-(100,30)-O-
b-glucopyranoside], known as isoverbascoside.
Compound 4: MALDI-TOF-MS spectrum of compound 4 is
quite different from those of compounds 1–3, it shows a
pseudomolecular ion peak at m/z 661 [M+Na]+ which is con-
sistent with the molecular formula C30H38O15Na., ESI-MS
spectrum showed quasimolecular ion peak at m/z 656
[M+H2O]
+, while ESI-MS/MS showed fragment ion peaks
at m/z 492 [M-rhamnosyl moiety]+, 485 [M-(aglycone moi-
ety+CH3)]
+, 339 [M-(aglycone moiety+rhamnosyl moi-
ety)]+. The complete assignment of all proton and carbon
resonances was based on the 1H, 13C, DEPT, COSY, HMQC,
andHMBC experiments. Compound 4 differs structurally from
compound (1) by the replacement of caffeic acid with ferulic
acid. This replacement was conﬁrmed through HMBC experi-
ment where the methoxy protons at dH 3.8 (3H, s, 300 0-OMe),
shows HMBC correlation to C-300 0 of ferulyl moiety at dC
147.9 (C-300 0). From the above mentioned data and comparing
with the literatures.8,12 compound 4 was conﬁrmed as 3,4-
dihydroxy-b-phenylethoxy-O-[400-E-feruloyl-a-rhamnopyrano-
syl-(100 0,300)-O-b-glucopyranoside], known as leucosceptosı´de A.
4.1. HPLC/UV characterization of the isolated phenylethanoids
Through comparison of different RP-HPLC retention times of
compounds 1ﬁ 3 (16.74, 17.91 and 18.68 min. respectively) it
was clear that no quite difference in their polarities, while the
delayed retention time (20.59 min) of compound 4 is attributedto methylation at position 3’’’ of the acyl moiety. The UV spec-
tra of all compounds show the same lambda maxima because
the responsible chromophoric group in all compounds is the
same one (a-unsaturated phenyl propionic acid). Of no impor-
tance is the difference in the UV-absorption intensities between
the derivatives, where it originated from the difference in the
concentration of the samples.
5. Conclusion
This research conﬁrms, for the ﬁrst time, the presence of
phenylethanoid glycosides in B. edulis, Acanthaceae. it also
conﬁrms the responsibility of the phenylethanoid derivatives
for antiradical activity of the methanol fraction. This research
identiﬁes and establishes HPLC/UV characteristics of the iso-
lated phenylethanoid derivative.
According to the anti DPPH experiment and the reported
biological activity of caffeoyl containing phenylethanoids,13–19
themethanol fraction ofB. edulis possesses promising biological
activities including: antimicrobial, antiinﬂammatory, immuno-
suppressive, antitumour, diuretic, antibacterial activities and
analgesic activities.References
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